Related Experiment Video
Updated: Sep 17, 2025

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Enabling isolation of an intrinsically amorphous API using a mesoporous carrier-assisted particle engineering
Tao Zhang1, Wei Ruan2, Joe Gao1
1Material & Analytical Sciences, Boehringer-Ingelheim, Ridgefield 06877 CT, United States.
This study presents a novel mesoporous silica carrier-assisted method for isolating amorphous Compound X, improving its physical properties. This approach enhances drug product manufacturing through direct compression and accelerates development timelines.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
- Chemical Engineering
Background:
- Intrinsically amorphous active pharmaceutical ingredients (APIs) often present challenges in isolation and downstream processing due to poor physicochemical properties.
- Developing scalable and efficient methods for handling amorphous APIs is crucial for pharmaceutical development.
Purpose of the Study:
- To develop and optimize a mesoporous silica-assisted isolation approach for an amorphous API (Compound X).
- To enhance the physicochemical properties of the isolated API, facilitating drug product manufacturing.
- To demonstrate the scalability and utility of the developed process using advanced analytical tools.
Main Methods:
- Utilized mesoporous silica as a carrier for API isolation.
- Employed in-situ process analytical tools (PAT) to investigate critical process parameters.
- Systematically studied carrier type, solvent composition, API-to-carrier ratio, and anti-solvent addition.
- Scaled the optimized process from gram to 200 g scale in a 5 L reactor.
Main Results:
- Achieved efficient isolation of amorphous Compound X with improved flowability and bulk density at a 1:1 API-to-carrier ratio.
- Demonstrated uniform API deposition onto the carrier surface.
- Successfully scaled the process, confirming its feasibility for larger production.
- The co-processed material exhibited excellent compressibility, tabletability, and compatibility (CTC), enabling direct compression.
- Full drug release was observed in biorelevant media (FaSSIF-V1).
Conclusions:
- Carrier-assisted API isolation, particularly with mesoporous silica, offers significant advantages for amorphous compounds.
- Integration of PAT accelerates process development and optimization.
- Co-processed APIs simplify downstream drug product manufacturing, enabling direct compression.
- This strategy addresses key challenges in developing intrinsically amorphous APIs.
More Related Videos
10:12Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
Published on: January 7, 2019
10:27Preparation of Highly Porous Coordination Polymer Coatings on Macroporous Polymer Monoliths for Enhanced Enrichment of Phosphopeptides
Published on: July 14, 2015
Related Concept Videos
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...